Axa cut its stake in shares of S&P Global Inc (NYSE:SPGI) by 11.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 259,833 sh
In a report released today, Scott Schneeberger from Oppenheimer maintained a Hold rating on FedEx (FDX – Research Report). The
New Mexico Educational Retirement Board reduced its position in Xylem Inc (NYSE:XYL) by 18.4% during the first quarter, according to the company in its most recent filing with the Securities and Excha
New Mexico Educational Retirement Board lessened its holdings in shares of Jack Henry & Associates, Inc. (NASDAQ:JKHY) by 19.2% in the 1st quarter, according to the company in its most recent 13F fili
Skandinaviska Enskilda Banken AB publ decreased its holdings in shares of United Rentals, Inc. (NYSE:URI) by 11.7% in the 1st quarter, according to the company in its most recent 13F filing with the S
AQR Capital Management LLC boosted its stake in shares of Pfenex Inc (NYSEAMERICAN:PFNX) by 243.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Ex
AQR Capital Management LLC trimmed its holdings in shares of Oppenheimer Holdings Inc. (NYSE:OPY) by 29.7% in the first quarter, according to its most recent Form 13F filing with the SEC. The institut
Royal Bank of Canada cut its stake in shares of EnPro Industries, Inc. (NYSE:NPO) by 7.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange
Oppenheimer initiated coverage on shares of Tandem Diabetes Care (NASDAQ:TNDM) in a research note published on Tuesday, TipRanks reports. The firm issued a buy rating and a $102.00 price target on the
Piper Sandler restated their buy rating on shares of Tandem Diabetes Care (NASDAQ:TNDM) in a research report sent to investors on Tuesday, TipRanks reports. The firm currently has a $90.00 price targe
Intercept Pharmaceuticals (NASDAQ:ICPT)‘s stock had its “buy” rating reissued by investment analysts at Wedbush in a research report issued to clients and investors on Monday, TipRanks reports.
Corbus Pharmaceuticals (NASDAQ:CRBP)‘s stock had its “buy” rating reaffirmed by research analysts at Oppenheimer in a report released on Monday, AnalystRatings.com reports. They presently have a
Akoustis Technologies (NASDAQ:AKTS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Monday, Zacks.com reports. According to Zac
EnPro Industries, Inc. (NYSE:NPO) – Investment analysts at Oppenheimer reduced their Q4 2020 EPS estimates for shares of EnPro Industries in a research report issued to clients and investors on Thur
Boeing is on track for its best month since 1982. This is the key level to watch now, says Oppenheimer's Ari Wald.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE